1 (Image 1)
Chemical structure of norethindrone acetate and ethinyl estradiol, as presented in the product Finzala by Teva Pharmaceuticals USA, Inc.*
Finzala Kit
Product Images NDC 0093-8210
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Finzala (NDC 0093-8210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Image 2)
Chemical structure of norethindrone acetate and ethinyl estradiol, active ingredients in Finzala. The diagram depicts the steroidal framework including acetate and ethynyl functional groups characteristic of the molecules.*
1 (Image 3)
A line graph showing norethindrone concentration (pg/mL) over time (hours) up to 36 hours. The graph depicts a peak concentration shortly after time zero, followed by a gradual decline with error bars indicating variability at each time point.*
1 (Image 4)
A line graph depicting ethinyl estradiol concentration (pg/mL) over time (hours). The graph shows concentration rising sharply to a peak before gradually declining and leveling off by 36 hours, with error bars indicating variability at each time point.*
1 (Image 5)
An illustration depicting contraceptive effectiveness ranked by pregnancy rates per 100 women per year. It categorizes methods from fewer than 1 pregnancy to 85 or more pregnancies per 100 women, listing implants, injections, intrauterine devices, and sterilization as most effective, down to no birth control as least effective.*
1 (Image 6)
An instructional diagram for Finzala 1 mg/20 mcg tablets kit, showing a 28-day pill dosing calendar organized by weeks and days of the week (Sunday through Saturday). Arrows indicate to start in the first pill circle for both Sunday and Day-1 starters and to take pills from left to right each week. The label advises Day-1 starters to place the day label strip starting with the first day of their period. Storage and child safety information is included, along with the labeler name Teva.*
1 (Image 7)
Finzala kit containing norethindrone acetate and ethinyl estradiol and ferrous fumarate tablets, USP, 1 mg/20 mcg, mint flavor. The packaging indicates a 28-day regimen with three blister cards, 28 tablets total. Labeler is Teva Pharmaceuticals USA, Inc.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
